Thorpe-Beeston J G, Nicolaides K H, Felton C V, Butler J, McGregor A M
Department of Obstetrics and Gynaecology, Harris Birthright Research Centre for Fetal Medicine, London, United Kingdom.
N Engl J Med. 1991 Feb 21;324(8):532-6. doi: 10.1056/NEJM199102213240805.
Data on human fetal thyroid function have largely been derived from histologic studies or studies of cord-blood samples obtained at hysterotomy or delivery. These data may not represent true normal values. Cordocentesis (ultrasound-guided blood sampling from the umbilical cord) is a technique that allows investigation of physiologic processes in fetuses not under stress.
We measured serum thyroid-stimulating hormone, total and free thyroxine (T4), total and free triiodothyronine (T3), and thyroxine-binding globulin in blood samples from 62 fetuses. The samples were obtained by cordocentesis (n = 58) or cardiocentesis (n = 4) at 12 to 37 weeks of gestation. Maternal serum samples were obtained immediately before fetal blood sampling.
Fetal serum thyroid-stimulating hormone, thyroxine-binding globulin, and total and free T4 and T3 concentrations increased significantly with the length of gestation (P less than 0.001). The only significant association among these variables, independent of the length of gestation, was between thyroid-stimulating hormone and free T4 (P less than 0.0001). Maternal serum concentrations of these variables did not change during gestation, and there was no significant relation between fetal and maternal values. Most fetal serum concentrations of thyroid-stimulating hormone were higher, whereas most serum total and free T3 concentrations were lower than the respective values for normal adults. The fetal serum total T4, free T4, and thyroxine-binding globulin values reached the level of the mean adult values at approximately 36 weeks of gestation.
The increases in fetal serum concentrations of thyroid-stimulating hormone, thyroxine-binding globulin, and total and free T4 and T3 during gestation reflect increasing maturation of the pituitary, thyroid, and liver. The finding of increasing fetal serum concentrations of thyroid-stimulating hormone in the presence of increasing thyroid hormone concentrations suggests that the sensitivity of the fetal pituitary gland to negative feedback is limited or is counterbalanced by increasing stimulation by thyrotropin-releasing hormone from the hypothalamus.
关于人类胎儿甲状腺功能的数据大多来自组织学研究或在子宫切开术或分娩时采集的脐血样本研究。这些数据可能并不代表真正的正常值。脐带穿刺术(超声引导下从脐带采血)是一种能够研究未处于应激状态胎儿生理过程的技术。
我们测量了62例胎儿血样中的血清促甲状腺激素、总甲状腺素和游离甲状腺素(T4)、总三碘甲状腺原氨酸和游离三碘甲状腺原氨酸(T3)以及甲状腺素结合球蛋白。样本在妊娠12至37周时通过脐带穿刺术(n = 58)或心脏穿刺术(n = 4)获取。在采集胎儿血样前立即采集母体血清样本。
胎儿血清促甲状腺激素、甲状腺素结合球蛋白以及总T4、游离T4、总T3和游离T3浓度随妊娠时间显著增加(P < 0.001)。在这些变量中,独立于妊娠时间的唯一显著关联是促甲状腺激素与游离T4之间的关联(P < 0.0001)。这些变量的母体血清浓度在妊娠期间没有变化,胎儿与母体的值之间也没有显著关系。大多数胎儿血清促甲状腺激素浓度高于正常成年人的相应值,而大多数血清总T3和游离T3浓度低于正常成年人的相应值。胎儿血清总T4、游离T4和甲状腺素结合球蛋白值在妊娠约36周时达到成人平均值水平。
妊娠期间胎儿血清促甲状腺激素、甲状腺素结合球蛋白以及总T4、游离T4、总T3和游离T3浓度的增加反映了垂体、甲状腺和肝脏的成熟度增加。在甲状腺激素浓度增加的情况下,胎儿血清促甲状腺激素浓度也增加,这一发现表明胎儿垂体对负反馈的敏感性有限,或者被来自下丘脑的促甲状腺激素释放激素增加的刺激所抵消。